Veeva Systems Inc Class A (VEEV) — chart, structure and Closelook read

Pick a ticker to load its detail page.

Company snapshot — Veeva Systems Inc Class A

VEEV in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Veeva Systems sells cloud software built for life sciences firms, covering commercial functions, clinical trial management, regulatory submissions, quality and drug safety records in one connected system. Its Vault products hold the underlying data, and it also runs data services that supply reference and patient information to pharmaceutical and biotechnology clients. It is based in Pleasanton, United States, and lists on the Nasdaq.
Where it sits in the stack
Veeva sits in our Agentic Winners 40 index, within the Application Leaders sleeve — vendors whose stored customer and operational data becomes the record any AI agent must consult. Because clinical trial, regulatory and safety data live inside its vault, agents built for pharma workflows are effectively customers of that data layer.
Who it is priced against
Closelook's peer group places it with other Application Leaders names — Adobe, Intuit, monday.com, HubSpot, Atlassian, PTC, Dassault Systemes and Kingdee — on the reasoning that these firms hold sticky enterprise data agents must plug into; the diary also notes Salesforce as the comparison the market draws in its life-sciences and CRM overlap.
Why Closelook tracks it
Veeva holds a seat in our Agentic Winners 40 index and carries a Closelook score, where momentum is the strongest module and valuation the weakest. The diary has quoted it in a Dossier on agentic winners for owning the pharma workflow, in a SaaSpocalypse mapping piece alongside Salesforce, and in a Midday 10 note on a large single-day share move.
What the diary watches
The diary watches whether momentum keeps outrunning valuation, and whether life-sciences agent development stays tied to Veeva's vault or migrates toward broader enterprise data platforms.

Veeva Systems Inc Class A (VEEV) trades on US exchanges, classified under Healthcare. Constituent of Agentic Winners 40.

The Closelook company score reads 59/100 composite (momentum 81, quality 73, valuation 31) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for VEEV, from the same nightly bakes the boards use. Research diary readings, not advice.

The Street on this name 2 analyst actions on the wire · latest: price target by Guggenheim, 2026-08-20 · last print 2026-08-26

The Street on this name

Analyst actions and the latest print for VEEV from the Closelook wires — third-party opinions on the record, not our readings.

  • Price target Guggenheim — target 276 Target set to $276 (+10% to spot) 2026-08-20
  • Price target Barclays — target 275 from 235 Target raised to $275 from $235 (+15.4% to spot) 2026-08-18
  • Latest print EPS 2.35 against 2.23 expected — a +5.4% beat 2026-08-26

2 actions on the analyst wire since 2026-08-13: 2 target changes. Analyst wire → · Earnings wire →

Who it is priced against Agentic Winners 40 · Application Leaders · 8 names with week and year-to-date

Compared against VEEV on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Versus its index Agentic Winners 40 — the name, its sleeve and the index over day, week and month

Versus its index

The name against its Closelook index and its own sleeve — equal-weight, nightly closes.

Agentic Winners 40 · as of 2026-09-17

DayWeekMonth3 months
VEEV−0.4%+1.1%+8.7%+70.3%
Application Leaders+0.8%+4.0%+2.1%
Agentic Winners 40+0.4%+2.1%+0.5%

Against the index: 1.0 pts behind on the week, 8.2 pts ahead on the month; against its Application Leaders sleeve 6.6 pts ahead on the month.

Returns from the index workers’ nightly closes; equal-weight sleeves. A relative reading from the research diary, not advice.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sector × region Health care in US: +0.7% week · +0.4% month · +10.2% quarter · +6.7% yearThe Sector Engine cell this name lives in, from XLV.US; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-09-16
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is Veeva Systems Inc Class A (VEEV)?

Veeva Systems Inc Class A trades as VEEV on the US exchange (US) and is classified under Healthcare in the Closelook research universe, as of the registry build of 2026-09-18.

Is VEEV in a Closelook index?

Yes — Veeva Systems Inc Class A is a constituent of Agentic Winners 40, as of 2026-09-18.

What is Veeva Systems Inc Class A's Closelook composite score?

59 out of 100, with momentum 81, quality 73 and valuation 31 sub-scores, as of 2026-09-18. Scores are Closelook's own research readings, not ratings or investment advice.

Where does VEEV trade against its moving averages?

-0.4% at the close: Holding 15.1% off its 52-week high. As of 2026-09-17 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

How is VEEV doing against its Closelook index?

Over the past month Veeva Systems Inc Class A is +8.7% against +0.5% for the Agentic Winners 40 — 8.2 points ahead of its index, as of 2026-09-17. Its Application Leaders sleeve is +2.1% over the same month. The “Versus its index” table on this page carries the day, the week and the month for the name, its sleeve and the index.

What does Veeva Systems Inc Class A do?

Veeva Systems sells cloud software built for life sciences firms, covering commercial functions, clinical trial management, regulatory submissions, quality and drug safety records in one connected system. Its Vault products hold the underlying data, and it also runs data services that supply reference and patient information to pharmaceutical and biotechnology clients. It is based in Pleasanton, United States, and lists on the Nasdaq. Closelook's peer group places it with other Application Leaders names — Adobe, Intuit, monday.com, HubSpot, Atlassian, PTC, Dassault Systemes and Kingdee — on the reasoning that these firms hold sticky enterprise data agents must plug into; the diary also notes Salesforce as the comparison the market draws in its life-sciences and CRM overlap.

Where does Veeva Systems Inc Class A sit in the AI build-out?

Veeva sits in our Agentic Winners 40 index, within the Application Leaders sleeve — vendors whose stored customer and operational data becomes the record any AI agent must consult. Because clinical trial, regulatory and safety data live inside its vault, agents built for pharma workflows are effectively customers of that data layer. Veeva holds a seat in our Agentic Winners 40 index and carries a Closelook score, where momentum is the strongest module and valuation the weakest. The diary has quoted it in a Dossier on agentic winners for owning the pharma workflow, in a SaaSpocalypse mapping piece alongside Salesforce, and in a Midday 10 note on a large single-day share move.

What has Wall Street done on Veeva Systems Inc Class A recently?

The most recent analyst action on Veeva Systems Inc Class A on the Closelook wire is a price target by Guggenheim on 2026-08-20 (target 276). 2 actions on the analyst wire since 2026-08-13: 2 target changes. Its latest earnings print on the wire, 2026-08-26: EPS 2.35 against 2.23 expected — a +5.4% beat. Analyst actions are third-party opinions recorded by the wire, not Closelook readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

Where has Closelook written about Veeva Systems Inc Class A?

Veeva Systems Inc Class A appears in 4 Closelook pieces, most recently Midday 10: The morning chip slide rounds back to flat; oil takes the bid (2026-08-31); Dossier: The Agentic Winners 25 (2026-03-31); Daily Pulse: Introducing the Agentic Winners 25 (2026-03-31). What Closelook said most recently: VEEV adds 4.14% to 288.14, a meaningful gain for a large-cap life-sciences software name on a day when the broader Software (IGV) complex is only fractionally green. (Midday 10, 2026-08-31). The "Mentioned on Closelook" block on this page lists the long reads, the reference entries and the dailies that name it.

What does this page show?

A live price chart with SMA overlays and drawing tools for VEEV, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Mentioned on Closelook 4 pieces · newest: Midday 10, “The morning chip slide rounds back to flat; oil takes the bid” (2026-08-31)

Mentioned on Closelook

Where VEEV appears in the diary — 4 pieces, newest first. Every link is our own writing.

Long reads

  • The Agentic Winners 25Dossier · $49 · 31 Mar 2026Veeva Systems owns the pharma and life sciences workflow — clinical trials, regulatory submissions, and drug safety data live in Veeva's vault, and any agent operating in that domain must interface with it.
  • Agentic Application Software: The SaaSpocalypse MapDossier · $39 · 27 Feb 2026Salesforce (CRM) · Veeva (VEEV) · HubSpot (HUBS, partial — mid-market data less sticky) Enterprise Data Platforms Fortress — AI increases demand Cross-reference with Strand 2: the data platforms covered in infrastructure analysis also…

Dailies

  • The morning chip slide rounds back to flat; oil takes the bidMidday 10 · 31 Aug 2026VEEV adds 4.14% to 288.14, a meaningful gain for a large-cap life-sciences software name on a day when the broader Software (IGV) complex is only fractionally green.
  • Introducing the Agentic Winners 25Daily Pulse · 31 Mar 202625 names across 7 sectors: MAG7 Gateway (MSFT, GOOGL, AAPL), Platform (SAP, NOW, CRM, WDAY), Toll Booth (NET, DDOG, CRWD, TWLO, OKTA), Neocloud/Edge (DOCN, FSLY, QCOM), Data/Search (SNOW, MDB, ESTC), Vertical (VEEV, INTU, PTC, CSGP, IOT)…

Related in the Closelook universe